131 related articles for article (PubMed ID: 28669752)
1. Novel molecular adaptation in cancer treatment and diagnostics: The importance of molecular, cellular and ethical aspects in an emerging field.
Simonson OE
Semin Cancer Biol; 2017 Aug; 45():1-2. PubMed ID: 28669752
[No Abstract] [Full Text] [Related]
2. Advanced Companion Diagnostics Facilities: Opportunity Favors the Prepared Laboratory.
Gruver AM; Schade AE
Arch Pathol Lab Med; 2015 Oct; 139(10):1201. PubMed ID: 26414461
[No Abstract] [Full Text] [Related]
3. Next-generation companion diagnostics: promises, challenges, and solutions.
Khoury JD; Catenacci DV
Arch Pathol Lab Med; 2015 Jan; 139(1):11-3. PubMed ID: 25166874
[No Abstract] [Full Text] [Related]
4. Next-generation sequencing in the clinic: are we ready?
Biesecker LG; Burke W; Kohane I; Plon SE; Zimmern R
Nat Rev Genet; 2012 Nov; 13(11):818-24. PubMed ID: 23076269
[TBL] [Abstract][Full Text] [Related]
5. The evolving potential of companion diagnostics.
Khoury JD
Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
[TBL] [Abstract][Full Text] [Related]
6. Co-development of a companion diagnostic for targeted cancer therapy.
Cheng S; Koch WH; Wu L
N Biotechnol; 2012 Sep; 29(6):682-8. PubMed ID: 22391147
[TBL] [Abstract][Full Text] [Related]
7. Liquid Profiling of Circulating Nucleic Acids as a Novel Tool for the Management of Cancer Patients.
Holdenrieder S
Adv Exp Med Biol; 2016; 924():53-60. PubMed ID: 27753019
[TBL] [Abstract][Full Text] [Related]
8. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
Walk EE
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
[TBL] [Abstract][Full Text] [Related]
9. Challenges for the implementation of routine molecular diagnostics in cancer care.
de Castro DG
Expert Rev Mol Diagn; 2011 Jul; 11(6):549-51. PubMed ID: 21745007
[No Abstract] [Full Text] [Related]
10. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
[TBL] [Abstract][Full Text] [Related]
11. Ethical and legal aspects of cancer genetic testing.
Offit K; Thom P
Semin Oncol; 2007 Oct; 34(5):435-43. PubMed ID: 17920900
[TBL] [Abstract][Full Text] [Related]
12. Aspects of molecular diagnostics and therapy in obstetrics and gynecology.
Beckmann MW; Strick R; Strissel PL; Fasching PA; Oppelt P; Pöhls UD; Malur SU; Ackermann S
Expert Rev Mol Diagn; 2003 May; 3(3):279-87. PubMed ID: 12779004
[TBL] [Abstract][Full Text] [Related]
13. Fujirebio Diagnostics to develop cancer diagnostics.
Expert Rev Mol Diagn; 2002 Mar; 2(2):93. PubMed ID: 11962340
[No Abstract] [Full Text] [Related]
14. NIR-Cyanine Dye Linker: a Promising Candidate for Isochronic Fluorescence Imaging in Molecular Cancer Diagnostics and Therapy Monitoring.
Komljenovic D; Wiessler M; Waldeck W; Ehemann V; Pipkorn R; Schrenk HH; Debus J; Braun K
Theranostics; 2016; 6(1):131-41. PubMed ID: 26722379
[TBL] [Abstract][Full Text] [Related]
15. Cancer diagnostics: The journey from histomorphology to molecular profiling.
Ahmed AA; Abedalthagafi M
Oncotarget; 2016 Sep; 7(36):58696-58708. PubMed ID: 27509178
[TBL] [Abstract][Full Text] [Related]
16. Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
Polivka J; Pesta M; Janku F
Expert Rev Mol Diagn; 2015; 15(12):1631-44. PubMed ID: 26559503
[TBL] [Abstract][Full Text] [Related]
17. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
Papadopoulos N; Kinzler KW; Vogelstein B
Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
[TBL] [Abstract][Full Text] [Related]
18. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
19. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
Mitra AP; Lin H; Cote RJ; Datar RH
Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnostics: impact upon cancer detection.
Keesee SK
Expert Rev Mol Diagn; 2002 Mar; 2(2):91-2. PubMed ID: 11962339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
